Tuberculous meningitis in HIV-infected patients: drug susceptibility and clinical outcome

AIDS. 2007 Jan 30;21(3):373-4. doi: 10.1097/QAD.0b013e328012b84d.

Abstract

The objective of this study was to identify prognostic factors of death in patients with tuberculous meningitis (TM) and show the impact of infection by multidrug-resistant strains on the outcome of this disease. We retrospectively analysed clinical charts of HIV-infected patients with culture-confirmed TM attending our institution during 1996-2004. The following variables were associated with death during hospitalization: neurological signs at admission, a CD4 T-cell count less than 50 cells/microl and infection by multidrug-resistant strains.

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy*
  • AIDS-Related Opportunistic Infections / immunology
  • AIDS-Related Opportunistic Infections / microbiology
  • Adult
  • Antitubercular Agents / therapeutic use*
  • Female
  • Humans
  • Male
  • Prognosis
  • Retrospective Studies
  • Treatment Outcome
  • Tuberculosis, Meningeal / drug therapy*
  • Tuberculosis, Meningeal / immunology
  • Tuberculosis, Meningeal / microbiology
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • Tuberculosis, Multidrug-Resistant / immunology
  • Tuberculosis, Multidrug-Resistant / microbiology

Substances

  • Antitubercular Agents